Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Two out of the three major indices are trading lower today with the Dow Jones Industrial Average ( ^DJI) trading down 29.64 points (-0.2%) at 18,195 as of Thursday, Feb. 26, 2015, 3:25 PM ET. The NYSE advances/declines ratio sits at 1,400 issues advancing vs. 1,601 declining with 167 unchanged.

The Health Services industry as a whole closed the day up 0.4% versus the S&P 500, which was down 0.4%. Top gainers within the Health Services industry included Escalon Medical ( ESMC), up 4.6%, Huttig Building Products ( HBP), up 2.9%, American Caresource Holdings ( ANCI), up 5.8%, Hooper Holmes ( HH), up 2.6% and Akers Biosciences ( AKER), up 2.6%.

TheStreet Ratings Group would like to highlight 3 stocks pushing the industry higher today:

Akers Biosciences ( AKER) is one of the companies that pushed the Health Services industry higher today. Akers Biosciences was up $0.10 (2.6%) to $3.92 on light volume. Throughout the day, 7,892 shares of Akers Biosciences exchanged hands as compared to its average daily volume of 16,900 shares. The stock ranged in a price between $3.83-$3.92 after having opened the day at $3.91 as compared to the previous trading day's close of $3.82.

Akers Biosciences has a market cap of $18.7 million and is part of the health care sector. Shares are down 4.3% year-to-date as of the close of trading on Wednesday.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

At the close, Hooper Holmes ( HH) was up $0.02 (2.6%) to $0.58 on average volume. Throughout the day, 91,323 shares of Hooper Holmes exchanged hands as compared to its average daily volume of 86,800 shares. The stock ranged in a price between $0.55-$0.63 after having opened the day at $0.56 as compared to the previous trading day's close of $0.57.

Hooper Holmes, Inc., together with its subsidiaries, provides health risk assessment services to the life insurance and health industries in the United States. The company operates through three segments: Health and Wellness, Heritage Labs, and Hooper Holmes Services. Hooper Holmes has a market cap of $39.4 million and is part of the health care sector. Shares are up 7.9% year-to-date as of the close of trading on Wednesday. Currently there are no analysts who rate Hooper Holmes a buy, no analysts rate it a sell, and none rate it a hold.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

TheStreet Ratings rates Hooper Holmes as a sell. The company's weaknesses can be seen in multiple areas, such as its disappointing return on equity, poor profit margins and weak operating cash flow.

Highlights from TheStreet Ratings analysis on HH go as follows:

  • Return on equity has greatly decreased when compared to its ROE from the same quarter one year prior. This is a signal of major weakness within the corporation. Compared to other companies in the Health Care Providers & Services industry and the overall market, HOOPER HOLMES INC's return on equity significantly trails that of both the industry average and the S&P 500.
  • The gross profit margin for HOOPER HOLMES INC is rather low; currently it is at 23.54%. It has decreased from the same quarter the previous year. Along with this, the net profit margin of -16.60% is significantly below that of the industry average.
  • Net operating cash flow has decreased to -$3.75 million or 17.75% when compared to the same quarter last year. In addition, when comparing to the industry average, the firm's growth rate is much lower.
  • HOOPER HOLMES INC reported significant earnings per share improvement in the most recent quarter compared to the same quarter a year ago. This company has not demonstrated a clear trend in earnings over the past 2 years, making it difficult to accurately predict earnings for the coming year. During the past fiscal year, HOOPER HOLMES INC reported poor results of -$0.17 versus -$0.11 in the prior year.
  • The net income growth from the same quarter one year ago has exceeded that of the S&P 500, but is less than that of the Health Care Providers & Services industry average. The net income increased by 23.7% when compared to the same quarter one year prior, going from -$1.71 million to -$1.31 million.

You can view the full analysis from the report here: Hooper Holmes Ratings Report

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

American Caresource Holdings ( ANCI) was another company that pushed the Health Services industry higher today. American Caresource Holdings was up $0.17 (5.8%) to $3.04 on light volume. Throughout the day, 1,378 shares of American Caresource Holdings exchanged hands as compared to its average daily volume of 10,600 shares. The stock ranged in a price between $2.89-$3.08 after having opened the day at $3.08 as compared to the previous trading day's close of $2.87.

American CareSource Holdings, Inc. provides access to a network of ancillary healthcare service providers in the United States. American Caresource Holdings has a market cap of $19.4 million and is part of the health care sector. Shares are down 0.9% year-to-date as of the close of trading on Wednesday. Currently there are no analysts who rate American Caresource Holdings a buy, no analysts rate it a sell, and none rate it a hold.

TheStreet Ratings rates American Caresource Holdings as a sell. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share, deteriorating net income and disappointing return on equity.

Highlights from TheStreet Ratings analysis on ANCI go as follows:

  • AMERICAN CARESOURCE HLDGS's earnings per share declined by 46.7% in the most recent quarter compared to the same quarter a year ago. The company has suffered a declining pattern earnings per share over the past two years. During the past fiscal year, AMERICAN CARESOURCE HLDGS reported poor results of -$0.66 versus -$0.54 in the prior year.
  • The company, on the basis of change in net income from the same quarter one year ago, has significantly underperformed when compared to that of the S&P 500 and the Health Care Providers & Services industry. The net income has significantly decreased by 69.6% when compared to the same quarter one year ago, falling from -$0.86 million to -$1.46 million.
  • Return on equity has greatly decreased when compared to its ROE from the same quarter one year prior. This is a signal of major weakness within the corporation. Compared to other companies in the Health Care Providers & Services industry and the overall market, AMERICAN CARESOURCE HLDGS's return on equity significantly trails that of both the industry average and the S&P 500.
  • Net operating cash flow has increased to -$0.87 million or 37.60% when compared to the same quarter last year. Despite an increase in cash flow of 37.60%, AMERICAN CARESOURCE HLDGS is still growing at a significantly lower rate than the industry average of 151.10%.
  • Compared to its closing price of one year ago, ANCI's share price has jumped by 37.85%, exceeding the performance of the broader market during that same time frame. Regarding the future course of this stock, we feel that the risks involved in investing in ANCI do not compensate for any future upside potential, despite the fact that it has seen nice gains over the past 12 months.

You can view the full analysis from the report here: American Caresource Holdings Ratings Report

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.